The Janus activated kinase (JAK)/STAT3 signaling pathway plays a prominent role in MM, which is activated by interleukin-6 and by loss of Src homology phosphatase -1 (SHP-1) [119,120,121]. Here, IL6 is linked to Miyoshi myopathy.